SCHEMBL7699050

SCHEMBL7699050

CCOC(=O)c1cc2c(C)ccc(F)c2o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
AKR1B1 P15121 1/20 0.45
HDAC4 P56524 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
GPR35 Q9HC97 1/20 0.43
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
ALOX5 P09917 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
DHODH Q02127 1/20 0.39
SLC2A1 P11166 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24522302 0.88 AKR1B1 (0.49) MAOBAKR1B1HDAC4HDAC6GPR35
SCHEMBL30587208 0.86 MAOB (0.45) MAOBAKR1B1HDAC4HDAC6GPR35
SCHEMBL26113710 0.86 MAOB (0.45) MAOBAKR1B1HDAC4HDAC6GPR35
SCHEMBL27185752 0.83 AKR1B1 (0.45) MAOBAKR1B1HDAC4HDAC6GPR35
SCHEMBL19744184 0.80 AKR1B1 (0.54) MAOBAKR1B1GPR35TP53THRB
SCHEMBL2303899 0.77 MAOA (0.51) MAOBHDAC4HDAC6KDM4EALDH1A1
SCHEMBL28373335 0.76 MAOB (0.59) MAOBAKR1B1HDAC4HDAC6KDM4E
SCHEMBL28368123 0.75 MAOB (0.57) MAOBAKR1B1HDAC4HDAC6KDM4E
SCHEMBL19744146 0.75 GPR35 (0.60) MAOBAKR1B1HDAC4HDAC6GPR35
SCHEMBL29540395 0.75 GPR35 (0.60) MAOBAKR1B1HDAC4HDAC6GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376491-B1 BENZOFURAN DERIVATIVES FOR TREATMENT OR PREVENTION OF MYCOSIS IN MAMMALS BASILEA PHARMACEUTICA AG (CH) 2002-04-23 US disclosed